Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis

IMPORTANCE: HIV preexposure prophylaxis (PrEP) is a key component of the Ending the HIV Epidemic (EHE) Initiative to curb new HIV diagnoses. In October 2019, emtricitabine/tenofovir alafenamide was added as an approved formulation for PrEP in addition to emtricitabine/tenofovir disoproxil fumarate;...

Descripción completa

Detalles Bibliográficos
Autores principales: McManus, Kathleen A., Fuller, Benjamin, Killelea, Amy, Strumpf, Andrew, Powers, Samuel D., Rogawski McQuade, Elizabeth T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638648/
https://www.ncbi.nlm.nih.gov/pubmed/37948076
http://dx.doi.org/10.1001/jamanetworkopen.2023.42781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638648/
https://www.ncbi.nlm.nih.gov/pubmed/37948076
http://dx.doi.org/10.1001/jamanetworkopen.2023.42781

Ejemplares similares